Rebecca Olin, MD
Professor
Medicine
School of Medicine

In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant.

Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania.

• Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
  Clinical lymphoma, myeloma & leukemia 2024 Konopleva MY, Dail M, Daver NG, Garcia JS, Jonas BA, Yee KWL, Kelly KR, Vey N, Assouline S, Roboz GJ, Paolini S, Pollyea DA, Tafuri A, Brandwein JM, Pigneux A, Powell BL, Fenaux P, Olin RL, Visani G, …
• It's All in the Timing.
  The New England journal of medicine 2023 Beagle AJ, Sunwoo BY, Olin RL, Schwartz BS, Block BL
• Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
  Journal of geriatric oncology 2023 Huang LW, Shi Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Boscardin WJ, Steinman MA, Olin RL
• Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients.
  Bone marrow transplantation 2023 Lee A, Badgley C, Lo M, Banez MT, Graff L, Damon L, Martin T, Dzundza J, Wong M, Olin R
• Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies.
  Blood advances 2023 Tsang M, Bischoff K, Schoenbeck KL, Berry K, O'Riordan D, Fakhri B, Wong SW, Shah N, Olin R, Andreadis C, Vieaux J, Cohen E, Lopez NS, Mannis GN, Rabow M
• Lack of disease control remains a major barrier to transplant for older patients with AML.
  Bone marrow transplantation 2023 Jeng MY, Kong D, Rajalingam R, Lin RJ, Olin RL
• Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.
  Blood advances 2023 Saliba AN, Kaufmann SH, Stein EM, Patel PA, Baer MR, Stock W, Deininger M, Blum W, Schiller GJ, Olin RL, Litzow MR, Lin TL, Ball BJ, Boyiadzis MM, Traer E, Odenike O, Arellano ML, Walker A, Duong VH, …
• PHASE II/III STUDY OF R-MINICHOP ± ORAL AZACITIDINE IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH DIFFUSE LARGE B CELL AND RELATED LYMPHOMAS.
  Hematological Oncology 2023 E. A. Brem, H. Li, A. W. Beaven, P. Caimi, L. Cerchietti, R. L. Olin, N. L. Henry, H. Dilon, R. F. Little, M. L. Leblanc, B. Kahl, J. P. Leonard, J. W. Friedberg, S. M. Smith
• Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2023 Pollyea DA, Altman JK, Assi R, Bixby D, Fathi AT, Foran JM, Gojo I, Hall AC, Jonas BA, Kishtagari A, Lancet J, Maness L, Mangan J, Mannis G, Marcucci G, Mims A, Moriarty K, Mustafa Ali M, Neff J, …
• The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients.
  Transplantation and cellular therapy 2023 Wall SA, Olin R, Bhatt V, Chhabra S, Munshi P, Hacker E, Hashmi S, Hassel H, Howard D, Jayani R, Lin R, McCurdy S, Mishra A, Murthy H, Popat U, Wood W, Rosko AE, Artz A
• Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
  Cancer 2023 Duong VH, Ruppert AS, Mims AS, Borate U, Stein EM, Baer MR, Stock W, Kovacsovics T, Blum W, Arellano ML, Schiller GJ, Olin RL, Foran JM, Litzow MR, Lin TL, Patel PA, Foster MC, Redner RL, Al-Mansour Z…
• Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma.
  Transplantation and cellular therapy 2023 Reyes KR, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Olin RL, Martin T, Shah N, Banerjee R
• Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
  Blood 2023 Daver NG, Dail M, Garcia JS, Jonas BA, Yee KWL, Kelly KR, Vey N, Assouline S, Roboz GJ, Paolini S, Pollyea DA, Tafuri A, Brandwein JM, Pigneux A, Powell BL, Fenaux P, Olin RL, Visani G, Martinelli G, …
• North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
  Blood 2023 Pemmaraju N, Kantarjian H, Sweet K, Wang E, Senapati J, Wilson NR, Konopleva M, Frankel AE, Gupta V, Mesa R, Ulrickson M, Gorak E, Bhatia S, Budak-Alpdogan T, Mason J, Garcia-Romero MT, Lopez-Santiago…
• 304 HLA-DPB1 Mismatch Permissiveness and Activating KIR Haplotypes Have Different Impact on Allogeneic Hematopoietic Cell Transplant Survival Outcomes in Acute Leukemias and Myelodysplastic Syndrome.
  Transplantation and Cellular Therapy 2023 Jerry Lee, Raja Rajalingam, Denice Kong, Weiyun Ai, Charalambos B. Andreadis, Lloyd E. Damon, Neil Dunavin, Karin M. Gaensler, Lawrence D. Kaplan, Thomas G. Martin, Rebecca L. Olin, Peter H. Sayre, …
• Improved Gvhd and Relapse Free Survival Outcomes in Older Acute Leukemia Patients Receiving Young Haploidentical Donor Vs Older Matched Sibling Donor Reduced Intensity Conditioning Hematopoietic Cell Transplants.
  Blood 2022 Andrew H. Tam, Aaron C. Logan, Angela J. Choi, Richard Fong, Lloyd E. Damon, Rebecca L. Olin, Neil Dunavin, Peter H. Sayre, Karin L. Gaensler, Catherine Smith, Lily Yan
• Cancer and Aging.
  2022 Ashley E. Rosko, Carolyn J. Presley, Grant R. Williams, Rebecca L. Olin
• Severe electrolyte derangements from lysozymuria in acute myeloid leukemia.
  EJHaem 2022 Pérez-Pinzón J, Olin RL, Banerjee R
• Geriatric assessment in adults age 50 years and older undergoing autologous hematopoietic cell transplantation for lymphoma.
  Journal of geriatric oncology 2022 Kennedy VE, Huang CY, Kaplan LD, Andreadis C, Ai WZ, Olin RL
• Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
  Transplantation and cellular therapy 2022 Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Huang CY, Olin RL
• Transplantation for Older Adults-More Questions than Answers.
  Transplantation and cellular therapy 2021 McCurdy SR, Olin RL
• S1918: A Phase II/III Randomized Study of R-Minichop with or without Oral Azacitidine (CC-486) in Participants Age 75 Years or Older with Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIb Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements.
  Blood 2021 Elizabeth A Brem, Hongli Li, Anne W. Beaven, Paolo F. Caimi, Leandro Cerchietti, Ash A. Alizadeh, Rebecca L. Olin, Norah Lynn Henry, Hildy Dilon, Richard F. Little, Cara Laubach, Michael L. Leblanc, …
• SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty tool.
  Journal of geriatric oncology 2021 Brem EA, Li H, Beaven AW, Caimi PF, Cerchietti L, Alizadeh AA, Olin R, Henry NL, Dillon H, Little RF, Laubach C, LeBlanc M, Friedberg JW, Smith SM
• Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care.
  The Lancet. Haematology 2021 Kennedy VE, Olin RL
• Physically "fit" for allogeneic stem cell transplant?
  Bone marrow transplantation 2021 Jayani RV, Olin RL
• Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.
  Blood cancer discovery 2021 Wang VE, Blaser BW, Patel RK, Behbehani GK, Rao AA, Durbin-Johnson B, Jiang T, Logan AC, Settles M, Mannis GN, Olin R, Damon LE, Martin TG, Sayre PH, Gaensler KM, McMahon E, Flanders M, Weinberg V, Ye…
• Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.
  Transplantation and cellular therapy 2021 Mishra A, Preussler JM, Bhatt VR, Bredeson C, Chhabra S, D'Souza A, Dahi PB, Hacker ED, Gowda L, Hashmi SK, Howard DS, Jakubowski A, Jayani R, Koll T, Lin RJ, Olin RL, Popat UR, Rodriguez C, Rosko A, …
• Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis.
  Infection control and hospital epidemiology 2021 Trinh TD, Strnad L, Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BAC, Yang K, Doernberg SB
• Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults.
  Transplantation and cellular therapy 2021 Sugidono M, Lo M, Young R, Rosario K, Jung Y, Huang CY, Sheng Y, Huang LW, Olin RL
• NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
  Journal of the National Comprehensive Cancer Network : JNCCN 2021 Pollyea DA, Bixby D, Perl A, Bhatt VR, Altman JK, Appelbaum FR, de Lima M, Fathi AT, Foran JM, Gojo I, Hall AC, Jacoby M, Lancet J, Mannis G, Marcucci G, Martin MG, Mims A, Neff J, Nejati R, Olin R, …
• Enasidenib (ENA) Monotherapy with Addition of Azacitidine in Non-Responders Is Effective in Older Patients with Newly Diagnosed IDH2 Mutated Acute Myeloid Leukemia (AML): A Completed Phase 2/1b Sub-Study of the Beat AML Master Trial.
  Blood 2020 Eytan M. Stein, Ying Huang, Uma Borate, Maria R. Baer, Wendy Stock, Tibor Kovacsovics, William Blum, Gary J. Schiller, Rebecca L. Olin, James M. Foran, Mark Litzow, Tara Lin, Prapti A. Patel, Matthew …
• Excellent Outcomes Achieved with Medical Management of Chronic Phase CML Patients with Non-Hematologic TKI Intolerance.
  Blood 2020 Kelly L. Schoenbeck, Sirisha Tummala, Rebecca L. Olin, Neha G. Goyal, Anand Dhruva, Lloyd E. Damon, Aaron C. Logan, Catherine C. Smith, Neil P. Shah
• Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.
  Nature medicine 2020 Burd A, Levine RL, Ruppert AS, Mims AS, Borate U, Stein EM, Patel P, Baer MR, Stock W, Deininger M, Blum W, Schiller G, Olin R, Litzow M, Foran J, Lin TL, Ball B, Boyiadzis M, Traer E, Odenike O, …
• Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.
  Journal of geriatric oncology 2020 Nawas MT, Sheng Y, Huang CY, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Olin RL
• Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
  Cancer 2020 Munshi PN, Vesole D, Jurczyszyn A, Zaucha JM, St Martin A, Davila O, Agrawal V, Badawy SM, Battiwalla M, Chhabra S, Copelan E, Kharfan-Dabaja MA, Farhadfar N, Ganguly S, Hashmi S, Krem MM, Lazarus HM,…
• Multidisciplinary Management of Cancer During Pregnancy.
  JCO oncology practice 2020 Silverstein J, Post AL, Chien AJ, Olin R, Tsai KK, Ngo Z, Van Loon K
• Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies.
  Journal of geriatric oncology 2020 Jaggers JL, Giri S, Klepin HD, Wildes TM, Olin RL, Artz A, Wall S, Jaglowski S, William B, Benson DM, Rosko AE
• Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
  Blood advances 2020 Zhou Z, Nath R, Cerny J, Wang HL, Zhang MJ, Abdel-Azim H, Agrawal V, Ahmed G, Al-Homsi AS, Aljurf M, Alkhateeb HB, Assal A, Bacher U, Bajel A, Bashir Q, Battiwalla M, Bhatt VR, Byrne M, Cahn JY, Cairo…
• Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.
  Blood advances 2020 Olin RL, Fretham C, Pasquini MC, Arora M, Bhatt VR, Derman B, Giralt SA, Huang LW, Koll T, Lee SM, Lin RJ, Pang L, Popat UR, Weisdorf DJ, Artz A
• Early and sustained improvement in fatigue-related quality of life following red blood cell transfusion in outpatients.
  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2020 Bruhn R, Karafin MS, Hilton JF, Kaidarova Z, Spencer BR, Qu L, Snyder EL, Olin R, Murphy EL, St Lezin E, NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS)-III Program
• The Evolving Role of Transplant for Older Adults.
  2020 Andrew S. Artz, Rebecca L. Olin
• Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
  Hematology. American Society of Hematology. Education Program 2019 Olin RL
• Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
  Blood 2019 Olin RL
• Use of geriatric assessment in hematopoietic cell transplant.
  Journal of geriatric oncology 2019 Jayani R, Rosko A, Olin R, Artz A
• A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).
  Blood 2019 Courtney D. DiNardo, Rebecca Olin, Jo Ishizawa, Hiroyuki Sumi, Jingdong Xie, Kazunobu Kato, Prasanna Kumar, Michael Andreeff
• Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies.
  Blood 2019 Jordon Jaggers, Heidi D. Klepin, Tanya M. Wildes, Rebecca L. Olin, Andrew S. Artz, Sarah A Wall, Samantha Jaglowski, Basem M. William, Don M. Benson, Ashley E. Rosko
• Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A Multicenter Retrospective Study.
  Blood 2019 Rebecca L. Olin, Caitrin Fretham, Marcelo C. Pasquini, Mukta Arora, Vijaya R. Bhatt, Benjamin Derman, Sergio A Giralt, Li-Wen Huang, Thuy T. Koll, Sang Mee Lee, Richard J Lin, Linda Pang, Uday Popat, …
• Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms.
  Blood 2019 Kelly L. Schoenbeck, Giselle Salmasi, Miguel Carlos Cerejo, Patricia A. Cornett, Lloyd E. Damon, Aaron C. Logan, Rebecca L. Olin, Andrew D. Leavitt, Catherine C. Smith
• Efficacy of Venetoclax Combination Therapy with Hypomethylating Agents in Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
  Blood 2019 Varun Mittal, Mimi Lo, Lloyd E. Damon, Karin L. Gaensler, Thomas G. Martin, Rebecca L. Olin, Catherine C. Smith, Aaron C. Logan
• Precision Medicine Treatment in Older AML: Results of Beat AML Master Trial.
  Blood 2019 Amy Burd, Ross L. Levine, Amy S. Ruppert, Alice S. Mims, Uma Borate, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael W. Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin,…
• Symptom Assessment in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms at an Academic Medical Institution.
  Blood 2019 Kelly L. Schoenbeck, Miguel Carlos Cerejo, Patricia A. Cornett, Lloyd E. Damon, Karin L. Gaensler, Andrew D. Leavitt, Aaron C. Logan, Gabriel N. Mannis, Rebecca L. Olin, Giselle Salmasi, Peter H. …
• Updated Results from the Venetoclax (Ven) in Combination with Idasanutlin (Idasa) Arm of a Phase 1b Trial in Elderly Patients (Pts) with Relapsed or Refractory (R/R) AML Ineligible for Cytotoxic Chemotherapy.
  Blood 2019 Naval G. Daver, Jacqueline S Garcia, Brian A Jonas, Kevin R Kelly, Sarit Assouline, Joseph M Brandwein, Pierre Fenaux, Rebecca L. Olin, Giovanni Martinelli, Stefania Paolini, Arnaud Pigneux, Daniel A …
• Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
  The New England journal of medicine 2019 Perl AE, Martinelli G, Cortes JE, Neubauer A, Berman E, Paolini S, Montesinos P, Baer MR, Larson RA, Ustun C, Fabbiano F, Erba HP, Di Stasi A, Stuart R, Olin R, Kasner M, Ciceri F, Chou WC, Podoltsev …
• 1089. Implementation of a Febrile Neutropenia Management Algorithm on Antibiotic Use and Outcomes: An Interrupted Time Series Analysis.
  Open Forum Infectious Diseases 2019 Trang D Trinh, Luke Strnad, Lloyd E Damon, John H Dzundza, Larissa R Graff, Laura M Griffith, Alexandra Hilts-Horeczko, Rebecca L Olin, Samantha Shenoy, Catherine DeVoe, Lusha Wang, Rosa Rodriguez-…
• Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Steinman MA, Huang CY, Olin RL
• Inflammatory biomarkers and patient-reported outcomes in acute myeloid leukemia: Refocusing on older adults.
  Journal of geriatric oncology 2019 Huang LW, Olin RL
• Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.
  Blood advances 2019 Rashidi A, Hamadani M, Zhang MJ, Wang HL, Abdel-Azim H, Aljurf M, Assal A, Bajel A, Bashey A, Battiwalla M, Beitinjaneh AM, Bejanyan N, Bhatt VR, Bolaños-Meade J, Byrne M, Cahn JY, Cairo M, Ciurea S, …
• Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2019 Tallman MS, Wang ES, Altman JK, Appelbaum FR, Bhatt VR, Bixby D, Coutre SE, De Lima M, Fathi AT, Fiorella M, Foran JM, Hall AC, Jacoby M, Lancet J, LeBlanc TW, Mannis G, Marcucci G, Martin MG, Mims A,…
• Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Wieduwilt MJ, Pawlowska N, Thomas S, Olin R, Logan AC, Damon LE, Martin T, Kang M, Sayre PH, Boyer W, Gaensler KML, Anderson K, Munster PN, Andreadis C
• Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
  Current oncology reports 2019 Huang LW, Wong SW, Andreadis C, Olin RL
• Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 Nawas MT, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Huang CY, Olin RL
• Functional Status Is Associated with Outcomes after Allogeneic Stem Cell Transplantation for Older Patients with Hematologic Malignancies.
  Blood 2018 Li-Wen Huang, Chiung-Yu Huang, Charalambos Andreadis, Aaron C. Logan, Gabriel N. Mannis, Catherine C. Smith, Karin M. Gaensler, Thomas G. Martin, Lloyd E. Damon, Michael A. Steinman, Rebecca L. Olin
• Safety, Efficacy, Pharmacokinetic (PK) and Biomarker Analyses of BCL2 Inhibitor Venetoclax (Ven) Plus MDM2 Inhibitor Idasanutlin (idasa) in Patients (pts) with Relapsed or Refractory (R/R) AML: A Phase Ib, Non-Randomized, Open-Label Study.
  Blood 2018 Naval G. Daver, Daniel A Pollyea, Jacqueline S. Garcia, Brian A. Jonas, Karen W.L. Yee, Pierre Fenaux, Sarit Assouline, Norbert Vey, Rebecca Olin, Gail J. Roboz, Agostino Tafuri, Giuseppe Visani, …
• Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).
  Journal of Clinical Oncology 2018 Sara Nunnery, Dorothy Wang, Marisela Tan, Richard Fong, Mimi Ming Lo, Rebecca L. Olin
• Impact of patient reported functional limitation on overall survival in older adults undergoing autologous hematopoietic cell transplant (AutoHCT).
  Journal of Clinical Oncology 2018 Mariam T. Nawas, Charalambos Andreadis, Thomas G. Martin, Jeffrey Lee Wolf, Weiyun Z. Ai, Lawrence D. Kaplan, Gabriel N. Mannis, Aaron Logan, Lloyd Earl Damon, Chiung-Yu Huang, Rebecca L. Olin
• A call to action in hematologic disorders: A report from the ASH scientific workshop on hematology and aging.
  Journal of geriatric oncology 2018 Rosko AE, Olin RL, Artz A, Wildes TM, Stauder R, Klepin HD
• The Evolving Role of Transplant for Older Adults.
  Geriatric Oncology 2018 Andrew S. Artz, Rebecca L. Olin
• Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults.
  Journal of geriatric oncology 2017 Huang LW, Olin RL
• Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.
  Blood 2017 Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'…
• Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2017 O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Bhatt V, Bixby D, Blum W, Coutre SE, De Lima M, Fathi AT, Fiorella M, Foran JM, Gore SD, Hall AC, Kropf P, Lancet J, Maness LJ, …
• CyFi: A phase I study exploring the role of cMET pathway inhibition with ficlatuzumab (Fi) combined with high-dose cytarabine (Cy) in patients with high risk relapsed or refractory acute myeloid leukemia (AML).
  Journal of Clinical Oncology 2017 Victoria Wang, Gabriel N. Mannis, Rebecca Leah Olin, Aaron Logan, Thomas G. Martin, Lloyd Earl Damon, Danielle Kilayko, Pamela N. Munster, Charalambos Andreadis
• Hematopoietic cell transplantation: Is there any age limit?.
  Hematopoietic Cell Transplants 2017 Andrew S. Artz, Rebecca L. Olin
• Phase 1 Dose Escalation Study of MDM2 Inhibitor DS-3032b in Patients with Hematological Malignancies - Preliminary Results.
  Blood 2016 Courtney D DiNardo, Joseph Rosenthal, Michael Andreeff, Oleg Zernovak, Prasanna Kumar, Roohi Gajee, Shuquan Chen, Michael Rosen, Saeheum Song, Jarema Kochan, Tharin Limsakun, Rebecca Olin
• Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research.
  Journal of geriatric oncology 2016 Magnuson A, Allore H, Cohen HJ, Mohile SG, Williams GR, Chapman A, Extermann M, Olin RL, Targia V, Mackenzie A, Holmes HM, Hurria A
• Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.
  Cancer 2016 Borthakur G, Popplewell L, Boyiadzis M, Foran J, Platzbecker U, Vey N, Walter RB, Olin R, Raza A, Giagounidis A, Al-Kali A, Jabbour E, Kadia T, Garcia-Manero G, Bauman JW, Wu Y, Liu Y, Schramek D, Cox…
• Biased and unbiased estimation in longitudinal studies with informative visit processes.
  Biometrics 2016 McCulloch CE, Neuhaus JM, Olin RL
• Comprehensive Genomic Profiling of Diagnostic Bone Marrow Specimens Identifies Mutational Profiles Predictive of Relapse in Patients with Acute Myeloid Leukemia Who Undergo Autologous Hematopoietic Cell Transplantation.
  Biology of Blood and Marrow Transplantation 2016 Gabriel N. Mannis, Shan Zhong, Michelle Nahas, Lily Kahira, Aaron C. Logan, Charalambos Andreadis, Lloyd E. Damon, Rebecca L. Olin, Sohail Balasubramanian, Jie He, Jo-Anne Vergilio, Tariq Mughal, …
• Improving venous thromboembolism (VTE) prophylaxis for hospitalized malignant hematology/bone marrow transplant (heme/BMT) patients.
  Journal of Clinical Oncology 2016 Melisa L. Wong, John Dzundza, Archana Ajmera, Ashley Gustafson, Mimi Lo, Richard Fong, Larissa Graff, Bao Dao, Rebecca Young, Lloyd Earl Damon, Thomas G. Martin, Rebecca Leah Olin
• Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2016 Mannis GN, Martin TG, Damon LE, Andreadis C, Olin RL, Kong KA, Faham M, Hwang J, Ai WZ, Gaensler KML, Sayre PH, Wolf JL, Logan AC
• Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission.
  Leukemia & lymphoma 2016 Mannis GN, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C
• Comorbidity in older adults with cancer.
  Journal of geriatric oncology 2015 Williams GR, Mackenzie A, Magnuson A, Olin R, Chapman A, Mohile S, Allore H, Somerfield MR, Targia V, Extermann M, Cohen HJ, Hurria A, Holmes H
• Panobinostat-Augmented Cytarabine and Daunorubicin (7+3) Induction for Older Patients with AML or High-Risk MDS Is Well Tolerated and Results in Favorable Clinical Outcomes: The Panda Trial.
  Blood 2015 Matthew J. Wieduwilt, Scott Thomas, Rebecca L. Olin, Aaron C. Logan, Lloyd E. Damon, Thomas G. Martin, McNancy Kang, Peter H. Sayre, Wanda Boyer, Karin ML Gaensler, Kirsten Anderson, Pamela Munster, …
• Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic Cell Transplantation.
  Blood 2015 Gabriel N. Mannis, Thomas G. Martin, Lloyd E. Damon, Charalambos Andreadis, Rebecca L. Olin, Katie Kong, Malek Faham, Weiyun Z. Ai, Karin ML Gaensler, Peter H. Sayre, Jeffrey L. Wolf, Aaron C. Logan
• Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
  Cancer 2015 Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE
• A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia.
  Clinical lymphoma, myeloma & leukemia 2015 Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG
• Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete Remission.
  Biology of Blood and Marrow Transplantation 2015 Gabriel N. Mannis, Thomas G. Martin, Lloyd E. Damon, Aaron C. Logan, Weiyun Ai, Karin M.L. Gaensler, Lawrence D. Kaplan, Anuj Mahindra, Rebecca L. Olin, Peter Sayre, Catherine C. Smith, Jeffrey L. …
• Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis.
  Bone marrow transplantation 2014 Mannis GN, Logan AC, Leavitt AD, Yanada M, Hwang J, Olin RL, Damon LE, Andreadis C, Ai WZ, Gaensler KM, Greene CC, Gupta NK, Kaplan LD, Mahindra A, Miyazaki Y, Naoe T, Ohtake S, Sayre PH, Smith CC, …
• Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
  Journal of geriatric oncology 2014 Keller JW, Andreadis C, Damon LE, Kaplan LD, Martin TG, Wolf JL, Ai WZ, Venstrom JM, Smith CC, Gaensler KM, Hwang J, Olin RL
• A Phase 1 Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination with Etoposide As Preparative Therapy for Autologous Stem Cell Transplant in Acute Myeloid Leukemia.
  Biology of Blood and Marrow Transplantation 2014 Gabriel N. Mannis, Lloyd E. Damon, Weiyun Ai, Charalambos Andreadis, Karin ML. Gaensler, Lawrence D. Kaplan, Aaron C. Logan, Anuj Mahindra, Rebecca L. Olin, Peter Sayre, Catherine C. Smith, Jeffrey M.…
• Comprehensive Geriatric Assessment Identifies Significant Functional Impairments in Older Hematopoietic Cell Transplant Recipients.
  Biology of Blood and Marrow Transplantation 2014 Rebecca L. Olin, Charalambos Andreadis, Thomas G. Martin, Jeffrey L. Wolf, Lawrence D. Kaplan, Weiyun Ai, Jeffrey M. Venstrom, Aaron C. Logan, Catherine C. Smith, Karin ML. Gaensler, Jimmy Hwang, …
• Delayed Hematopoietic Recovery After Autologous Stem Cell Transplantation In Patients Receiving Arsenic Trioxide-Based Therapy For Acute Promyelocytic Leukemia.
  Blood 2013 Gabriel N. Mannis, Lloyd E Damon, Weiyun Z. Ai, Charalambos Andreadis, Karin ML Gaensler, Neel K. Gupta, Lawrence D. Kaplan, Andrew D. Leavitt, Aaron C. Logan, Rebecca L. Olin, Peter H. Sayre, …
• David versus Goliath: decision analysis predicts results of a large clinical trial in follicular lymphoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Olin RL, Andreadis C
• Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients.
  Biology of Blood and Marrow Transplantation 2013 Jesse W. Keller, Lloyd E. Damon, Lawrence D. Kaplan, Thomas G. Martin, Jeffrey L. Wolf, Weiyun Z. Ai, Charalambos Andreadis, Jeffrey M. Venstrom, Catherine C. Smith, Karin M.L. Gaensler, Jimmy Hwang, …
• Phase I/II Trial of the MEK1/2 Inhibitor Trametinib (GSK1120212) in Relapsed/Refractory Myeloid Malignancies: Evidence of Activity in Patients with RAS Mutation-Positive Disease.
  Blood 2012 Gautam Borthakur, Leslie Popplewell, Michael Boyiadzis, James M. Foran, Uwe Platzbecker, Norbert Vey, Walter B. Roland, Rebecca L. Olin, Azra Raza, Aristotles Giagounidis, Oliver G. Ottmann, Aref Al-…
• Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis.
  American journal of hematology 2010 Olin RL, Kanetsky PA, Ten Have TR, Nasta SD, Schuster SJ, Andreadis C
• Allogeneic Transplantation for the Treatment of Multiple Myeloma.
  Allogeneic Stem Cell Transplantation 2010 Rebecca L. Olin, Dan T. Vogl, Edward A. Stadtmauer
• Choosing First-Line Therapy for Follicular Lymphoma (FL): A Decision Analysis.
  Blood 2008 Rebecca L. Olin, Peter A. Kanetsky, Thomas Ten Have, Sunita Dwivedy Nasta, Stephen J. Schuster, Charalambos Andreadis
• The Impact of Rituximab Resistance on Overall Survival Rate in Low-Grade Follicular Lymphoma.
  Blood 2008 Shahrzad Abdollahi, Elise A Chong, Rebecca L. Olin, Sunita D. Nasta, Charalambos Andreadis, Edward A Stadtmauer, Christopher C Lake, Lisa H Downs, Stephen J. Schuster
• Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma.
  Bone marrow transplantation 2008 Olin RL, Vogl DT, Porter DL, Luger SM, Schuster SJ, Tsai DE, Siegel DL, Cook RJ, Mangan PA, Cunningham K, Stadtmauer EA
• Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.
  American journal of hematology 2008 Olin RL, Nichols KE, Naghashpour M, Wasik M, Shelly B, Stadtmauer EA, Vogl DT
• Non-myopathic cardiac events in two patients treated with trastuzumab.
  The breast journal 2007 Olin RL, Desai SS, Fox K, Davidson R
• Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.
  Blood 2005 Rebecca L. Olin, David L. Porter, Selina M. Luger, Stephen J. Schuster, Donald Tsai, Sunita Nasta, Alexander Perl, Alison W. Loren, Steven Goldstein, Eli Glatstein, Donald L. Siegel, Dan T. Vogl, …
• Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma.
  Biology of Blood and Marrow Transplantation 2005 R.L. Olin, S.M. Luger, D.L. Porter, S.J. Schuster, D. Tsai, S. Nasta, A. Perl, A.W. Loren, S. Goldstein, P. Mangan, V. Sherry, K. Cunningham, B. Sachs, K. Hummel, E.A. Stadtmauer
• Pegfilgrastim Versus Filgrastim To Accelerate Hematopoietic Recovery after High Dose Melphalan and Autologous Hematopoietic Stem Cell Transplant (ASCT) for Multiple Myeloma.
  Blood 2004 Rebecca L. Olin, Selina M. Luger, David L. Porter, Stephen J. Schuster, Donald Tsai, Sunita Nasta, Alexander Perl, Alison W. Loren, Steven Goldstein, Patricia Mangan, Vicki Sherry, Kathleen Cunningham…